Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH

Journal:

Cell Metabolism

Published:

2026-01-06

DOI:

10.1016/j.cmet.2025.11.015

Affiliations:

10

Authors:

25

Go to article

Institutions	Authors	Share
McMaster University, Canada	11.500000 11.500000	0.46
Espervita Therapeutics, United States of America (USA)	4.000000	0.16
The University of Melbourne (UniMelb), Australia	3.500000	0.14
Physiogenex S.A.S., France	2.000000	0.08
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	2.000000	0.08
Austin Health, Australia	1.500000	0.06
University of Florida (UF), United States of America (USA)	0.500000	0.02

Interested in Medical Biochemistry and Metabolomics?